about
Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?Bioinformatics and HIV latency.Understanding HIV latency: the road to an HIV cureAn in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patientsActivation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapyMechanism and factors that control HIV-1 transcription and latency activationBridging HIV-1 cellular latency and clinical long-term non-progressor: an interactomic viewImpact of the Ku complex on HIV-1 expression and latency.Dynamics of HIV latency and reactivation in a primary CD4+ T cell model.Eradicating HIV-1 infection: seeking to clear a persistent pathogen.HIV Latency Is Established Directly and Early in Both Resting and Activated Primary CD4 T Cells.Temporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switchThe mTOR Complex Controls HIV Latency.Multiple UBXN family members inhibit retrovirus and lentivirus production and canonical NFκΒ signaling by stabilizing IκBα.Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradicationDevelopment of 5' LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individualsHIV-1 transcription and latency: an update.Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirsIdentification of glycoproteins associated with HIV latently infected cells using quantitative glycoproteomics.Therapy for latent HIV-1 infection: the role of histone deacetylase inhibitors.New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo.Cellular and molecular mechanisms involved in the establishment of HIV-1 latency.Pyroptosis, superinfection, and the maintenance of the latent reservoir in HIV-1 infection.Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator ComplexRole of the histone H3 lysine 9 methyltransferase Suv39 h1 in maintaining Epsteinn-Barr virus latency in B95-8 cells.Reactivation of latent HIV-1 by inhibition of BRD4.Dual-color HIV reporters trace a population of latently infected cells and enable their purification.A doubly fluorescent HIV-1 reporter shows that the majority of integrated HIV-1 is latent shortly after infection.HIV Provirus Stably Reproduces Parental Latent and Induced Transcription Phenotypes Regardless of the Chromosomal Integration Site.Latent HIV-1 can be reactivated by cellular superinfection in a Tat-dependent manner, which can lead to the emergence of multidrug-resistant recombinant viruses.Insight into HIV-2 latency may disclose strategies for a cure for HIV-1 infection.Effects of HIV on metabolic and biological pathways of CD4+ T lymphocytes.Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins.Mathematical modeling of viral infection dynamics in spherical organs.Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 InfectionPosttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3
P2860
Q26865388-B94CDA68-C130-49B6-BA01-DD039CBFE670Q28081427-12C0FFB8-D9CE-4D96-9F71-E0A6C76C6715Q28085296-C2A865BB-713D-4BAE-86F7-F7061446600AQ28538015-84E4FC3E-5DC4-40E4-898A-9F09E2553463Q28544949-FE678C08-15AD-47EC-8DEA-D809901B731AQ33826920-C85EAF53-202D-44B2-A650-829BC3241055Q34602260-BFDB758B-9DA9-4B72-B0FB-AA2830ADE35CQ34903532-F84C47C2-5759-4FC1-8C52-F71D64258092Q35176166-763B9410-5259-45E2-B4B0-1770AC90402BQ35252186-B2C593E6-5D1C-4818-ADA1-EE8F09867593Q35661660-6B9EF889-9B03-488E-8C81-279AFAC303D3Q36125264-EBAA559F-AB8C-45C3-B8B0-B2B0AA9192BEQ36225471-D347422A-8FE4-4769-BB74-05FDFEC36DC3Q36267881-D7238FD7-9FA8-4434-896F-DE14C1E79B29Q36330062-A560B32E-0790-4242-81A0-E7F1EC43E3A1Q36596027-952C7D48-E78C-4977-9940-A45AA5607F9FQ36976156-6AD57D2E-52AE-44F8-BED9-01324D4D45C2Q37273652-CD77D752-D70C-4BA8-96A5-643F371F00B1Q37383798-6EF0AA0A-842C-4310-8E72-E91E512F3B92Q37626634-EFDE38F6-7C18-4803-8033-CC66E4518BECQ37695001-FC940179-48DB-417E-8E3E-97A36136577CQ38078562-944F8435-9C23-4FE8-888B-524547B557B7Q38718273-9DF1FE5B-86C2-4891-95EC-C1078CAEF375Q38818673-5BC77D68-275F-478E-BEC4-EC58C255B72EQ39019130-68463BBD-68A2-4E14-A7FA-1E7E4489E1F9Q39264882-08073BE0-21F3-45D2-B748-826E9B7C9CA7Q39544604-E5920F80-78EA-4153-8097-EE961AD83106Q39794074-AC40CE43-F240-4615-B529-20994FFF4DABQ40752303-E6AA9778-7471-4440-BBF9-EF22319630AFQ41760939-30FED728-C4B8-40CF-8CDC-68BC01DE9D27Q42318282-5CA73A1C-15FA-41C5-B073-B1AD11912A24Q49875304-CC409CB7-1DDC-4470-A61C-1444FFC02FC2Q50022535-2E1AE6E9-DA7A-401F-8AC3-E266CACF7478Q51318158-5B03EABD-0DBF-4A7C-8ABB-87F1F9A12CA9Q57072848-029282A3-C882-4D29-A63B-11E2D8F9F343Q59132651-B2DCCCEF-F616-438C-A9D8-957FEBE00D68
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
HIV latency: experimental systems and molecular models.
@ast
HIV latency: experimental systems and molecular models.
@en
type
label
HIV latency: experimental systems and molecular models.
@ast
HIV latency: experimental systems and molecular models.
@en
prefLabel
HIV latency: experimental systems and molecular models.
@ast
HIV latency: experimental systems and molecular models.
@en
P2093
P2860
P1476
HIV latency: experimental systems and molecular models
@en
P2093
Kotaro Shirakawa
Leonard Chavez
Shweta Hakre
P2860
P304
P356
10.1111/J.1574-6976.2012.00335.X
P50
P577
2012-05-01T00:00:00Z